Hypertension, Vol 14, 461-468, Copyright © 1989 by American Heart Association
M Imanishi, M Kawamura, S Akabane, Y Matsushima, M Kuramochi, K Ito, M Ohta, K Kimura, M Takamiya and T Omae
To clarify the role of renal prostanoid in hyperreninemia and high blood
pressure in human renovascular hypertension, we measured prostaglandin E2
and renin activity in renal venous and abdominal aortic plasma before and
after the intravenous administration of the cyclooxygenase inhibitor,
aspirin DL-lysine. Subjects were six patients with unilateral renovascular
hypertension and six with essential hypertension. In patients with
renovascular hypertension, prostaglandin E2 concentration in renal venous
plasma from the stenotic kidney was 9.25 +/- 1.48 pg/ml, which was
significantly higher (p less than 0.01) than the concentration in the renal
venous plasma from the normal kidney (4.97 +/- 1.02 pg/ml) or in the aortic
plasma (2.59 +/- 0.15 pg/ml). Plasma renin activity was also higher in the
renal vein of the stenotic kidney than in the other two sites. The stenotic
side/normal side ratio of the renal venous prostaglandin E2 correlated
significantly with a renin ratio greater than 1.5 (r = 0.8211, p less than
0.05). Intravenous injection of aspirin DL-lysine (18 mg/kg) 30 minutes
later markedly suppressed prostaglandin E2 and renin levels at all sites
and clearly lowered arterial blood pressure (mean: from 120 +/- 6 to 110
+/- 5 mm Hg, p less than 0.01). The reduction in blood pressure correlated
significantly with the suppression of plasma renin activity in the aorta (p
less than 0.05) and in the renal vein of the stenotic kidney (p less than
0.01). Conversely, in patients with essential hypertension, aspirin had
little effect on renin levels and increased mean blood pressure.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Aspirin lowers blood pressure in patients with renovascular hypertension
Division of Hypertension and Nephrology, National Cardiovascular Center, Osaka, Japan.
This article has been cited by other articles:
![]() |
D. G. Hackam, J. D. Spence, A. X. Garg, and S. C. Textor Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension Hypertension, December 1, 2007; 50(6): 998 - 1003. [Full Text] [PDF] |
||||
![]() |
W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2644 - H2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Saremi, H. Jadvar, and M. E. Siegel Pharmacologic Interventions in Nuclear Radiology: Indications, Imaging Protocols, and Clinical Results RadioGraphics, May 1, 2002; 22(3): 477 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imanishi, T. Tsuji, S. Nakamura, and M. Takamiya Prostaglandin I2/E2 Ratios in Unilateral Renovascular Hypertension of Different Severities Hypertension, July 1, 2001; 38(1): 23 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Breyer and R. M. Breyer Prostaglandin E receptors and the kidney Am J Physiol Renal Physiol, July 1, 2000; 279(1): F12 - F23. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Wang, H.-F. Cheng, and R. C. Harris Cyclooxygenase-2 Inhibition Decreases Renin Content and Lowers Blood Pressure in a Model of Renovascular Hypertension Hypertension, July 1, 1999; 34(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imanishi, S. Akabane, M. Takamiya, M. Kawamura, Y. Matsushima, M. Kuramochi, and T. Omae Critical Degree of Renal Arterial Stenosis That Causes Hypertension in Dogs Angiology, October 1, 1992; 43(10): 833 - 842. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |